(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(123, '<div id="spr0_aef6a21"><div id="spr1_aef6a21" class="kern slide"><img id="img1_aef6a21" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef6a21" class="kern slide"><div id="spr3_aef6a21" style="left:20.727px;top:202.34px;"><div id="spr4_aef6a21"><img id="img0_aef6a21" src="data/img147.png" width="680.042" height="192.744" alt=""/></div><div id="spr5_aef6a21" style="top:0px;"><div style="width:0px;"><span id="txt0_aef6a21" data-width="86.578125" style="left:7.2px;top:14.964px;">Inhibitor</span></div></div><div id="spr6_aef6a21" style="left:137.452px;top:0px;"><div style="width:0px;"><span id="txt1_aef6a21" data-width="136.277344" style="left:9.555px;top:0.564px;">Neo-adjuvant</span></div><div style="width:0px;"><span id="txt2_aef6a21" data-width="101.906250" style="left:26.75px;top:29.364px;">treatment</span></div></div><div id="spr7_aef6a21" style="left:292.359px;top:0px;"><div style="width:0px;"><span id="txt3_aef6a21" data-width="192.093750" style="left:12.85px;top:0.564px;">Early Breast Cancer</span></div><div style="width:0px;"><span id="txt4_aef6a21" data-width="198.164063" style="left:10.005px;top:29.364px;">Adjuvant treatment</span></div></div><div id="spr8_aef6a21" style="left:509.452px;top:0px;"><div style="width:0px;"><span id="txt5_aef6a21" data-width="98.507813" style="left:35.468px;top:0.564px;">Advanced</span></div><div style="width:0px;"><span id="txt6_aef6a21" data-width="134.085938" style="left:17.823px;top:29.364px;">breast cancer</span></div></div><div id="spr9_aef6a21" style="top:64.8px;"><div style="width:0px;"><span id="txt7_aef6a21" data-width="116.027344" style="left:7.2px;top:0.564px;">Anastrozole</span></div></div><div id="spr10_aef6a21" style="left:137.452px;top:64.8px;"><div style="width:0px;"><span id="txt8_aef6a21" data-width="77.343750" style="left:39.745px;top:0.564px;">IMPACT</span></div></div><div id="spr11_aef6a21" style="left:292.361px;top:64.8px;"><div style="width:0px;"><span id="txt9_aef6a21" data-width="52.265625" style="left:84.383px;top:0.564px;">ATAC</span></div></div><div id="spr12_aef6a21" style="left:509.452px;top:64.8px;"><div style="width:0px;"><span id="txt10_aef6a21" data-width="77.167969" style="left:46.971px;top:0.564px;">TARGET</span></div></div><div id="spr13_aef6a21" style="top:100.8px;"><div style="width:0px;"><span id="txt11_aef6a21" data-width="118.640625" style="left:7.2px;top:10.164px;">Exemestane</span></div></div><div id="spr14_aef6a21" style="left:137.452px;top:100.8px;"><div style="width:0px;"><span id="txt12_aef6a21" data-width="130.634766" style="left:12.335px;top:1.07px;">Semiglazov et al</span></div><div style="width:0px;"><span id="txt13_aef6a21" data-width="40.546875" style="left:57.205px;top:25.07px;">2005</span></div></div><div id="spr15_aef6a21" style="left:292.361px;top:100.8px;"><div style="width:0px;"><span id="txt14_aef6a21" data-width="57.820313" style="left:79.738px;top:10.164px;">TEAM</span></div></div><div id="spr16_aef6a21" style="left:509.452px;top:100.8px;"><div style="width:0px;"><span id="txt15_aef6a21" class="relpos" data-width="70.558594" style="left:19.533px;top:10.164px;">EORTC </span><span id="txt16_aef6a21" class="relpos" data-width="60.820313" style="left:19.528px;top:10.164px;">10951</span></div></div><div id="spr17_aef6a21" style="top:156px;"><div style="width:0px;"><span id="txt17_aef6a21" data-width="90.679688" style="left:7.2px;top:0.564px;">Letrozole</span></div></div><div id="spr18_aef6a21" style="left:137.452px;top:156px;"><div style="width:0px;"><span id="txt18_aef6a21" data-width="54.316406" style="left:50.392px;top:0.564px;">P 024</span></div></div><div id="spr19_aef6a21" style="left:292.361px;top:156px;"><div style="width:0px;"><span id="txt19_aef6a21" data-width="83.507813" style="left:66.92px;top:0.564px;">BIG 1-98</span></div></div><div id="spr20_aef6a21" style="left:509.452px;top:156px;"><div style="width:0px;"><span id="txt20_aef6a21" data-width="54.316406" style="left:57.483px;top:0.564px;">P 025</span></div></div></div><div id="spr21_aef6a21" style="top:104.734px;"><div style="width:0px;"><span id="txt21_aef6a21" data-width="217.287109" style="left:251.688px;top:0.058px;">Post-menopause …</span></div></div><div id="spr22_aef6a21" style="left:-0px;top:145.932px;"><div style="width:0px;"><span id="txt22_aef6a21" data-width="265.634766" style="left:227.598px;top:1.07px;">Only ER+ve patients, of course …</span></div></div><div id="spr23_aef6a21" style="left:-0px;top:426.083px;"><div style="width:0px;"><span id="txt23_aef6a21" data-width="629.179688" style="left:45.762px;top:1.07px;">These are just a small fraction of trials in endocrine treatment and resistance.</span></div><div style="width:0px;"><span id="txt24_aef6a21" data-width="631.640625" style="left:45.482px;top:25.07px;">There are many more completed and on-going: phase I, II, III, post-approval …</span></div><div style="width:0px;"><span id="txt25_aef6a21" data-width="576.894531" style="left:73.688px;top:49.07px;">Focused on treatment efficacy, tolerability, combination, sequencing …</span></div></div><div id="spr24_aef6a21" style="top:-0.289px;"><div style="width:0px;"><span id="txt26_aef6a21" data-width="356.390625" style="left:68.556px;top:-0.448px;">Many trials have confirmed</span></div><div style="width:0px;"><span id="txt27_aef6a21" data-width="355.687500" style="left:69.586px;top:37.952px;">superiority of AIs over TAM</span></div></div></div></div>');})();